Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details)

v3.23.3
INVESTMENTS IN UNCONSOLIDATED JOINT VENTURES - Schedule of Equity Method Investment, Summarized Financial Information, Income Statement (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]        
Total revenues $ 71,482 $ 63,135 $ 206,943 $ 166,264
Operating and other expenses (15,349) (13,468) (41,557) (39,354)
Depreciation and amortization (23,212) (22,359) (70,543) (61,815)
Interest expense (23,715) (18,819) (67,422) (45,167)
Net loss (60,250) (105,902) (106,615) (75,779)
Equity Method Investment, Nonconsolidated Investee or Group of Investees        
Schedule of Equity Method Investments [Line Items]        
Total revenues 26,266 34,402 70,967 111,874
Operating and other expenses (9,107) (19,651) (26,236) (67,467)
Depreciation and amortization (5,591) (6,384) (16,728) (19,325)
Interest expense (7,520) (7,852) (22,995) (21,679)
Net loss $ 4,048 $ 515 $ 5,008 $ 3,403